highly significantP < 0.001
Repeated‐measures analysis results represented in Table 2 showed a highly significant decline in pain scores over time in both arms (time effect P < 0.001), with mean VAS falling from 4.33 ± 0.97 to 2.68 ± 0.81 to 1.53 ± 0.68 in the bupivacaine group and from 4.85 ± 1.05 to 3.16 ± 0.95 to 1.84 ± 0.71 in controls.